NVS
Novartis AG
Stock
$141.00−0.05 (−0.04%)Close Oct 2, 2026
- Capital expenditures, 2025
- $1.5B
- YoY, 2025
- +13.3%
- 5-year CAGR
- +4.0%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $1.5B | +13.3% |
| 2024 | $1.4B | +28.9% |
| 2023 | $1.1B | +15.7% |
| 2022 | $916M | −14.1% |
| 2021 | $1.1B | −16.4% |
| 2020 | $1.3B | −7.5% |
| 2019 | $1.4B | +10.0% |
| 2018 | $1.3B | −5.4% |
| 2017 | $1.3B | −28.8% |
| 2016 | $1.9B | — |